148 related articles for article (PubMed ID: 22864375)
1. Comparison of two different iron oxide-based contrast agents for discrimination of benign and malignant lymph nodes.
Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
Invest Radiol; 2012 Sep; 47(9):511-5. PubMed ID: 22864375
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of benign and malignant lymph nodes at 7.0T compared to 1.5T magnetic resonance imaging using ultrasmall particles of iron oxide: a feasibility preclinical study.
Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
Acad Radiol; 2013 Dec; 20(12):1604-9. PubMed ID: 24200489
[TBL] [Abstract][Full Text] [Related]
3. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model.
Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH
Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033
[TBL] [Abstract][Full Text] [Related]
4. Assessment of normal, inflammatory, and tumor-bearing lymph nodes with contrast-enhanced interstitial magnetic resonance lymphography: preliminary results in rabbits.
Herborn CU; Vogt FM; Lauenstein TC; Goyen M; Dirsch O; Corot C; Debatin JF; Ruehm SG
J Magn Reson Imaging; 2003 Sep; 18(3):328-35. PubMed ID: 12938128
[TBL] [Abstract][Full Text] [Related]
5. Iron oxide particle-enhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: how reliable are the results?
Baghi M; Mack MG; Wagenblast J; Hambek M; Rieger J; Bisdas S; Gstoettner W; Engels K; Vogl T; Knecht R
Anticancer Res; 2007; 27(5B):3571-5. PubMed ID: 17972519
[TBL] [Abstract][Full Text] [Related]
6. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) -- results of a phase-III multicenter clinical trial.
Sigal R; Vogl T; Casselman J; Moulin G; Veillon F; Hermans R; Dubrulle F; Viala J; Bosq J; Mack M; Depondt M; Mattelaer C; Petit P; Champsaur P; Riehm S; Dadashitazehozi Y; de Jaegere T; Marchal G; Chevalier D; Lemaitre L; Kubiak C; Helmberger R; Halimi P
Eur Radiol; 2002 May; 12(5):1104-13. PubMed ID: 11976854
[TBL] [Abstract][Full Text] [Related]
7. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer.
Rockall AG; Sohaib SA; Harisinghani MG; Babar SA; Singh N; Jeyarajah AR; Oram DH; Jacobs IJ; Shepherd JH; Reznek RH
J Clin Oncol; 2005 Apr; 23(12):2813-21. PubMed ID: 15837995
[TBL] [Abstract][Full Text] [Related]
9. Experimental lymph node metastases: enhanced detection with MR lymphography.
Weissleder R; Elizondo G; Josephson L; Compton CC; Fretz CJ; Stark DD; Ferrucci JT
Radiology; 1989 Jun; 171(3):835-9. PubMed ID: 2717761
[TBL] [Abstract][Full Text] [Related]
10. MR lymphography with iron oxide particles: dose-response studies and pulse sequence optimization in rabbits.
Hamm B; Taupitz M; Hussmann P; Wagner S; Wolf KJ
AJR Am J Roentgenol; 1992 Jan; 158(1):183-90. PubMed ID: 1727343
[TBL] [Abstract][Full Text] [Related]
11. [Lymph node diagnosis with imaging methods. An overview with special reference to recent developments in the area of MR contrast media].
Mohr U; Weissleder R
Z Lymphol; 1996 Jun; 20(1):15-20. PubMed ID: 8768044
[TBL] [Abstract][Full Text] [Related]
12. [Lymph node image with ultrasmall superparamagnetic iron oxide and comparison with pathological result].
Xue HD; Lei J; Li Z; Wang DT; Zhou WX; Dai W; Jin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):139-45. PubMed ID: 19507589
[TBL] [Abstract][Full Text] [Related]
13. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
Weissleder R; Elizondo G; Wittenberg J; Lee AS; Josephson L; Brady TJ
Radiology; 1990 May; 175(2):494-8. PubMed ID: 2326475
[TBL] [Abstract][Full Text] [Related]
14. Early MR lymphography with gadofluorine M in rabbits.
Misselwitz B; Platzek J; Weinmann HJ
Radiology; 2004 Jun; 231(3):682-8. PubMed ID: 15163808
[TBL] [Abstract][Full Text] [Related]
15. Anatomic and functional evaluation of the lymphatics and lymph nodes in diagnosis of lymphatic circulation disorders with contrast magnetic resonance lymphangiography.
Liu NF; Lu Q; Jiang ZH; Wang CG; Zhou JG
J Vasc Surg; 2009 Apr; 49(4):980-7. PubMed ID: 19223143
[TBL] [Abstract][Full Text] [Related]
16. Possible pathological basis for false diagnoses of lymph nodes by USPIO-enhanced MRI in rabbits.
Lei J; Xue HD; Li Z; Li S; Jin ZY
J Magn Reson Imaging; 2010 Jun; 31(6):1428-34. PubMed ID: 20512896
[TBL] [Abstract][Full Text] [Related]
17. Functional magnetic resonance imaging using iron oxide particles in characterizing head and neck adenopathy.
Hoffman HT; Quets J; Toshiaki T; Funk GF; McCulloch TM; Graham SM; Robinson RA; Schuster ME; Yuh WT
Laryngoscope; 2000 Sep; 110(9):1425-30. PubMed ID: 10983936
[TBL] [Abstract][Full Text] [Related]
18. [Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles in detecting lymph node metastasis of tumors: an experimental study].
Wu YK; Xu YK; Zhang JN; Wu FL; Liu XY; Huang QL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):62-4. PubMed ID: 12527520
[TBL] [Abstract][Full Text] [Related]
19. MR contrast agents in lymph node imaging.
Misselwitz B
Eur J Radiol; 2006 Jun; 58(3):375-82. PubMed ID: 16464554
[TBL] [Abstract][Full Text] [Related]
20. [Differentiation of axillary inflammatory and metastatic lymph nodes with diffusion-weighted imaging in animal modes].
Bai X; Liao Q; Wang JP; Bai RJ; Sun HR; Yu CS; Zhang YT
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(9):592-5. PubMed ID: 22800945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
